The Apolipoprotein B/Apolipoprotein AI Ratio in the Metabolic Syndrome—Should We Start Using It?

Authors

  • Justo Sierra-Johnson MD, MS,

    1. From the Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester MN;1 and the Department of Medicine, Atherosclerosis Research Unit, Karolinska Institutet, Stockholm, Sweden2
    Search for more papers by this author
  • 1,2 Abel Romero-Corral MD, MS,

    1. From the Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester MN;1 and the Department of Medicine, Atherosclerosis Research Unit, Karolinska Institutet, Stockholm, Sweden2
    Search for more papers by this author
  • 1 Virend K. Somers MD, PhD,

    1. From the Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester MN;1 and the Department of Medicine, Atherosclerosis Research Unit, Karolinska Institutet, Stockholm, Sweden2
    Search for more papers by this author
  • and 1 Francisco Lopez-Jimenez MD, MS 1

    1. From the Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester MN;1 and the Department of Medicine, Atherosclerosis Research Unit, Karolinska Institutet, Stockholm, Sweden2
    Search for more papers by this author

Justo Sierra-Johnson, MD, MS, Atherosclerosis Research Unit, Department of Medicine, Karolinska University Hospital, S-171 76, Stockholm, Sweden
E-mail: jusier@ki.se

No abstract is available for this article.

Ancillary